GOMIKA UDUGAMASOORIYA to Cell Line, Tumor
This is a "connection" page, showing publications GOMIKA UDUGAMASOORIYA has written about Cell Line, Tumor.
Connection Strength
0.662
-
Multimerization approach to improve a cell surface plectin binding cancer stem cell targeted peptoid drug-lead. Bioorg Chem. 2026 May; 172:109578.
Score: 0.138
-
A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells. Bioorg Chem. 2021 11; 116:105340.
Score: 0.102
-
Design of a dual ERK5 kinase activation and autophosphorylation inhibitor to block cancer stem cell activity. Bioorg Med Chem Lett. 2020 12 01; 30(23):127552.
Score: 0.095
-
A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1. Eur J Med Chem. 2017 Sep 08; 137:1-10.
Score: 0.076
-
A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1. Biochem Biophys Res Commun. 2017 04 29; 486(2):545-550.
Score: 0.075
-
Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1. Bioorg Med Chem. 2016 09 15; 24(18):4470-4477.
Score: 0.071
-
Linker optimization and activity validation of a cell surface vimentin targeted homo-dimeric peptoid antagonist for lung cancer stem cells. Bioorg Med Chem. 2024 01 01; 97:117560.
Score: 0.060
-
Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells. Sci Rep. 2019 10 18; 9(1):14954.
Score: 0.045